ADMET-score - a comprehensive scoring function for evaluation of chemical drug-likeness.
暂无分享,去创建一个
Hongbin Yang | Lixia Sun | Weihua Li | Guixia Liu | Yun Tang | Yingchun Cai | Longfei Guan | Peiwen Di | Weihua Li | Guixia Liu | Yun Tang | Hongbin Yang | Peiwen Di | Lixia Sun | Yingchun Cai | Longfei Guan
[1] Jie Shen,et al. admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties , 2012, J. Chem. Inf. Model..
[2] Asher Mullard. 2017 FDA drug approvals , 2018, Nature Reviews Drug Discovery.
[3] George Divine,et al. Exemplary data set sample size calculation for Wilcoxon–Mann–Whitney tests , 2009, Statistics in medicine.
[4] Matthew D Segall,et al. Multi-parameter optimization: identifying high quality compounds with a balance of properties. , 2012, Current pharmaceutical design.
[5] Robert Preissner,et al. WITHDRAWN—a resource for withdrawn and discontinued drugs , 2015, Nucleic Acids Res..
[6] Gunnar Rätsch,et al. Classifying 'Drug-likeness' with Kernel-Based Learning Methods , 2005, J. Chem. Inf. Model..
[7] George Papadatos,et al. The ChEMBL database in 2017 , 2016, Nucleic Acids Res..
[8] F. Cheng,et al. Insights into Molecular Basis of Cytochrome P450 Inhibitory Promiscuity of Compounds , 2011, J. Chem. Inf. Model..
[9] Matthew D Segall,et al. Addressing toxicity risk when designing and selecting compounds in early drug discovery. , 2014, Drug discovery today.
[10] Iskander Yusof,et al. Considering the impact drug-like properties have on the chance of success. , 2013, Drug discovery today.
[11] Tudor I. Oprea,et al. Understanding drug‐likeness , 2011 .
[12] Barry C. Jones,et al. DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS , 2004, Drug Metabolism and Disposition.
[13] Andreas Bender,et al. A Large Descriptor Set and a Probabilistic Kernel-Based Classifier Significantly Improve Druglikeness Classification , 2007, J. Chem. Inf. Model..
[14] Tingjun Hou,et al. Drug-likeness analysis of traditional Chinese medicines: prediction of drug-likeness using machine learning approaches. , 2012, Molecular pharmaceutics.
[15] Michael C Hutter,et al. Selecting Relevant Descriptors for Classification by Bayesian Estimates: A Comparison with Decision Trees and Support Vector Machines Approaches for Disparate Data Sets , 2011, Molecular informatics.
[16] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[17] Youyong Li,et al. ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage. , 2012, Molecular pharmaceutics.
[18] W. Patrick Walters,et al. A guide to drug discovery: Designing screens: how to make your hits a hit , 2003, Nature Reviews Drug Discovery.
[19] Ricardo Macarrón,et al. Yin and Yang in medicinal chemistry: what does drug-likeness mean? , 2011, Future medicinal chemistry.
[20] Tingjun Hou,et al. ADME Evaluation in Drug Discovery, 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property-Based Rules? , 2007, J. Chem. Inf. Model..
[21] A. Ghose,et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.
[22] T. Keller,et al. A practical view of 'druggability'. , 2006, Current opinion in chemical biology.
[23] I. Muegge,et al. Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.
[24] M. Bermejo,et al. In Silico Prediction of Caco‐2 Cell Permeability by a Classification QSAR Approach , 2011, Molecular informatics.
[25] Markus Wagener,et al. Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features , 2000, J. Chem. Inf. Comput. Sci..
[26] W Patrick Walters,et al. Prediction of 'drug-likeness'. , 2002, Advanced drug delivery reviews.
[27] Igor V. Pletnev,et al. Drug Discovery Using Support Vector Machines. The Case Studies of Drug-likeness, Agrochemical-likeness, and Enzyme Inhibition Predictions , 2003, J. Chem. Inf. Comput. Sci..
[28] Lei Yang,et al. Classification of Cytochrome P450 Inhibitors and Noninhibitors Using Combined Classifiers , 2011, J. Chem. Inf. Model..
[29] Jie Li,et al. admetSAR 2.0: web‐service for prediction and optimization of chemical ADMET properties , 2018, Bioinform..
[30] Jie Shen,et al. Estimation of ADME Properties with Substructure Pattern Recognition , 2010, J. Chem. Inf. Model..
[31] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[32] Miklos Feher,et al. Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..
[33] Dan Li,et al. The application of in silico drug-likeness predictions in pharmaceutical research. , 2015, Advanced drug delivery reviews.
[34] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[35] G. V. Paolini,et al. Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.
[36] Andreas Bender,et al. P-glycoprotein Substrate Models Using Support Vector Machines Based on a Comprehensive Data set , 2011, J. Chem. Inf. Model..
[37] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[38] Pär Matsson,et al. Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. , 2011, Journal of medicinal chemistry.
[39] Tudor I. Oprea,et al. A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. , 2011, Journal of medicinal chemistry.
[40] Klaus-Robert Müller,et al. Benchmark Data Set for in Silico Prediction of Ames Mutagenicity , 2009, J. Chem. Inf. Model..
[41] Xiao Li,et al. In Silico Prediction of Chemical Acute Oral Toxicity Using Multi-Classification Methods , 2014, J. Chem. Inf. Model..
[42] Ruili Huang,et al. Comprehensive Characterization of Cytochrome P450 Isozyme Selectivity across Chemical Libraries , 2009, Nature Biotechnology.
[43] Sanjivanjit K. Bhal,et al. The Rule of Five revisited: applying log D in place of log P in drug-likeness filters. , 2007, Molecular pharmaceutics.
[44] Gang Chen,et al. A New Rapid and Effective Chemistry Space Filter in Recognizing a Druglike Database , 2005, J. Chem. Inf. Model..
[45] Zengrui Wu,et al. In Silico Estimation of Chemical Carcinogenicity with Binary and Ternary Classification Methods , 2015, Molecular informatics.
[46] Jens Sadowski,et al. Comparison of Support Vector Machine and Artificial Neural Network Systems for Drug/Nondrug Classification , 2003, J. Chem. Inf. Comput. Sci..